Vote Scores
Filings read through

Avadel Pharmaceuticals plc: how funds voted at the meeting of 12 Jan 2026

Meeting
Season
year to 30 June 2026
Filers reporting
301
Ballot items
5

301 filers on Form N-PX reported votes at the Avadel Pharmaceuticals plc meeting of 12 Jan 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    403 vote records from 293 filers. 35 of the 277 filers that marked the item voted against management. 16 filers gave no management mark.

    • Positions of 40 fund families
    • For 35
    • Against 5
    • Against management 5
  2. Item 2: Advisory vote on pay tied to a merger or sale

    9 vote records from 7 filers. 0 of the 5 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 2 fund families
    • For 2
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    252 vote records from 82 filers. 0 of the 82 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 31
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    17 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of one fund family
    • For 1
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    407 vote records from 84 filers. 6 of the 84 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 29
    • Against 2
    • Against management 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Avadel Pharmaceuticals plc, meeting of 12 Jan 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Say-on-pay2. Merger pay
AllianceBernsteinAgainst, against managementNo report
American CenturyAgainst, against managementNo report
BairdForNo report
BlackRock and iSharesForNo report
BNY MellonForNo report
Brighthouse FundsForNo report
Charles SchwabForNo report
Columbia ThreadneedleForNo report
DimensionalForNo report
DWSForNo report
EquitableForNo report
Federated HermesForNo report
FidelityForNo report
First TrustForNo report
Franklin TempletonForNo report
Global XForNo report
Goldman SachsForNo report
Guggenheim and RydexForNo report
InvescoForNo report
J.P. MorganNo reportFor
Janus HendersonForNo report
John Hancock and ManulifeForNo report
Lincoln FinancialForFor
MassMutualForNo report
Morgan Stanley, Eaton Vance and CalvertForNo report
NationwideForNo report
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesAgainst, against managementNo report
Nuveen and TIAAAgainst, against managementNo report
Pacific Life fundsForNo report
PGIM and PrudentialForNo report
PrincipalForNo report
ProShares and ProFundsForNo report
Russell InvestmentsForNo report
SEIForNo report
State Street and SPDRForNo report
T. Rowe PriceForNo report
VanguardForNo report
VirtusForNo report
VoyaAgainst, against managementNo report

Questions

How many filers reported votes at the Avadel Pharmaceuticals plc meeting?
301 Form N-PX filers reported votes at the meeting of 12 Jan 2026. On say-on-pay, 35 of 277 filers that marked the item voted against management (12.6%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Avadel Pharmaceuticals plc reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Avadel Pharmaceuticals plc with a meeting date within three days of 12 Jan 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .